Infectious complications associated with immunomodulating biologic agents.
about
Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitorsMultifocal Colonic Wall Abscesses during Anti-Tumor Necrosis Factor (TNF)-α Therapy for a Patient with Ulcerative Colitis: A Very Rare Manifestation of Infectious Complications.Clinical use of anti-TNF therapy and increased risk of infectionsThe occurrence and prevention of foodborne disease in vulnerable people.Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune DisordersInfectious tenosynovitis with bloodstream infection caused by Erysipelothrix rhusiopathiae, a case report on an occupational pathogen.Beyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae.The role of integrin antagonists in the treatment of inflammatory bowel disease.Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.Histological characteristics of the abdominal aortic wall in patients with vascular chronic Q fever.In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis.Kocuria kristinae infection during adalimumab treatment.Cutaneous Cryptococcoma in a Patient on TNF-α InhibitionPulmonary mucormycosis in a patient with Crohn disease on immunosuppressive medications including infliximab.Introduction: Infections in solid organ transplantation.
P2860
Q29302324-E00F4098-9FFD-4F19-88D1-11A476479635Q32182441-3A15DC01-C3FA-4E8B-9799-5E839F24838AQ34338096-2DA9CDDE-6316-46D8-9CB2-AE60BF5D72E8Q35173590-D8F38ED3-4340-4C5C-BF11-D2AD6048443CQ36009655-7588C57B-5341-4FCB-B5A5-89DA0C79E25DQ36240803-8E5A65A3-D462-43CF-9CD7-8A548A838626Q38192553-E502CEA4-7515-42B9-BEAB-C42B4EF7D336Q38257410-1714C801-5AE5-4D6F-A30B-C2297E2787ECQ39264020-EEE75954-D73D-4911-8DBE-C86513DA68F0Q40202836-8253C124-09A0-4931-A05F-C0E80313C4E7Q40439491-D47869F1-06D4-4C3D-B099-00FC15C5C396Q40473306-62BCBF40-D0B8-4D0A-9720-0599E7BE69CFQ40666221-E8EBCB6A-810D-4489-9421-D214F7855538Q41898247-1F46DAA3-9B10-41C4-937A-C6AF9BBA9C73Q50483235-5A29D950-42B6-4323-9F00-7FB5C4CC9099
P2860
Infectious complications associated with immunomodulating biologic agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infectious complications associated with immunomodulating biologic agents.
@en
type
label
Infectious complications associated with immunomodulating biologic agents.
@en
prefLabel
Infectious complications associated with immunomodulating biologic agents.
@en
P50
P1476
Infectious complications associated with immunomodulating biologic agents
@en
P304
P356
10.1016/J.IDC.2010.01.006
P577
2010-06-01T00:00:00Z